Pregnancy outcome after exposure to the probiotic Lactobacillus in early pregnancy

Journal of Obstetrics and Gynaecology

Volumn 32, Issue 3, 2012, Pages 227-229

  Lee, J E ^a   Han, J Y ^a   Choi, J S ^a   Ahn, H K ^a   Lee, S W ^a   Kim, M H ^a   Ryu, H M ^a   Yang, J H ^a   Nava Ocampo, A A ^b,c,d   Koren, G ^b  

^a Cheil Hospital and Women's Healthcare Centre   (South Korea)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d PharmaReasons Pharmacological Research and Applied Solutions   (Canada)

Author keywords

Dietary supplements; maternal exposure; probiotics

Indexed keywords

PROBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; LACTOBACILLUS ACIDOPHILUS; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; SAMPLE SIZE; SPONTANEOUS ABORTION; TREATMENT DURATION;

ABORTION, SPONTANEOUS; ADULT; BIRTH WEIGHT; CONGENITAL ABNORMALITIES; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; LACTOBACILLUS; LIVE BIRTH; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREMATURE BIRTH; PROBIOTICS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 84863245483     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2011.641621     Document Type: Article

References (17)

1. Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor M, Garaiova I et al. 2010. Dietary supplementation with lactobacilli and bifi dobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. Journal of Nutrition 140:483-488.
2. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. 2004. Probiotics for treating infectious diarrhea. Cochrane Database of Systematic Reviews (2):CD003048.
3. Cho JS, Kim KS, Kim SY, Kim TY, Choi HM, Lim YK et al. 1997. Congenital anomalies diagnosed by antenatal ultrasonography. Korean Journal of Obstetrics and Gynecology 40:1228-1232.
4. Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR. 2009. Probiotics safety in pregnancy: A systemic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifi dobacterium, and Saccharomyces spp. Journal of Obstetrics and Gynaecology Canada 31:542-552.
5. Hallén A, Jarstrand C, Pahlson C. 1992. Treatment of bacterial vaginosis with lactobacilli. Sexually Transmitted Disease 19:146-148.
6. Han JY, Yang JH, Chung JH, Choi JS, Ahn HK, Ryu HM et al. 2005. Teratogen risk counselling by internet: A prospective cohort study. Journal of Obstetrics and Gynaecology 25:427-431.
7. Havenaar R, Huisin't Veld JHJ. 1992. Probiotics: A general view. In: Wood BJ, editor. The lactic acid bacteria in health and disease. Vol. 1. London: Elsevier Applied Science. p. 151-171.
8. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. 2001. Probiotics in primary prevention of atopic disease: A randomized placebo-controlled trial. Lancet 357: 1076-1079.
9. Neri A, Sabah G, Samra Z. 1993. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstetricia et Gynecologica Scandinavica 72:17-19.
10. Othman M, Neilson JP, Alfirevic Z. 2007. Probiotics for preventing preterm labour. Cochrane Database of Systematic Reviews (1):CD005941.
11. Penner R, Fedorak RN, Madsen KL. 2005. Probiotics and nutraceuticals: Non-medicinal treatments of gastrointestinal diseases. Current Opinion in Pharmacology 5:596-603.
12. Quigley EM. 2010. Probiotics in gastrointestinal disorders. Hospital Practice (Minneapolis) 38:122-129.
13. Rautava S, Kalliomäki M, Isolauri E. 2002. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. Journal of Allergy and Clinical Immunology 109:119-121.
14. Senok AC, Ismaeel AY, Botta GA. 2005. Probiotics: Facts and myths. Clinical Microbiology and Infection 11:958-966.
15. Ya W, Reifer C, Miller LE. 2010. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: A double-blind, randomized, placebo-controlled study. American Journal of Obstetrics and Gynecology 203:120.e1-e6.
16. Yakabe T, Takashima H, Kuwagata M, Fukao M, Kikuchi S, Yajima N. 2011. Teratogenicity and maternal effects of Lactobacillus brevis KB290 in rats and rabbits. Food and Chemical Toxicology 49:722-726.
17. Yang JH, Kim YJ, Chung JH, Kim MY, Ryu HM, Ahn HK et al. 2004. A multicenter study for birth defect monitoring systems in Korea. Journal of Korean Medical Sciences 19:509-513.